Acute and Subacute Toxicity studies on Siddha Herbo-mineral Anti-arthritic formulation "Pooneeru Diravagam" in experimental animal models
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2015, Vol 4, Issue 1
Abstract
Ethno pharmacological Relevance: 60% of the world's population depends on traditional medicine [1]. It is in use for primary health care and general health care among rural, urban, semi urban in both developed and developing countries parallel to the usage of western medicines. Pooneeru diravagam is an indigenous Siddha medicine [2]. There is a huge cry, tall fake claims regarding the safety and efficacy of Siddha formulations. The present study is aimed to evaluate the safety of Pooneeru diravagam by determining any toxicity changes through acute and sub-acute toxicity studies per oral administration in swiss albino rats. Materials and Methods: Acute toxicity study was carried out as per OECD Guideline-423 in healthy swiss albino female rat weighing 200–245 gm. The Study was carried out in three female rats under fasting condition; signs of toxicity were observed for every one hour for first 24 hours and every day for fortnight from the beginning of the study. Sub acute toxicity study was carried out as per OECD guidelines-407 in swiss albino rats of either sex weighing 220–245 gm of three groups of 6 rats each (Three male and three female) at two dosage levels 0.2 ml and 0.4 ml of 28 days continuous drug administration (oral route). Results: The animals were sacrificed on the 29th day and various blood biochemical parameters haematological and clinical signs were measured. The organ morphology such as kidney, liver, heart, lungs, spleen, pancreas, brain, ovaries and testes were processed for Histopathological study. The results of sub-acute toxicity on 29th day did not show any evidence of changes. Physiological, Hematological as well as Histopathological parameters remained unaltered when compared with control animals throughout the dosing period. Conclusions: From the results it is concluded that usage of pooneeru diravagam at the dosage of 0.4 ml/kg p.o is safe for the population suffering from rheumatoid arthritis.
Authors and Affiliations
Padhmavathi J
Keywords
Related Articles
- EP ID EP201706
- DOI 10.19070/2167-910X-1500025
- Views 74
- Downloads 0
Decomposition of Concentration-Time Profiles after Oral Administration of Different Ethanol Doses in Humans
A new physiologically-motivated structural model capable of evaluating ethanol behavior within the whole-body blood metabolism was developed. This model was estimated on the basis of a reanalysis of the mean blood ethano...
Tragedies in Clinical Trials - A History Wrapped Up
Today foremost emphasis is being given to the protection of patient’s safety and ethics during the conduct of clinical trials. Serious considerations by regulatory authorities are taken to safeguard the patient’s right,...
Antioxidant Effects of Vitamin E in Diabetes Mellitus Type 1
In diabetes mellitus atherosclerosis is precocious, accelerated, and extensive, having influence to a large extent the secondary dislipoproteinemia to the hyper-glucemia, the lipoprotein’s glucosilation produce changes i...
Steady State Plasma Levels of Bupropion After Administration of 3x150 Mg Extended Release Reference Tablets and Switching to 1x450 Mg Extended Release 450ER Tablets
In order to provide patients who take 450 mg/day bupropion hydrochloride for the treatment of severe depressive disorder with a safe and convenient alternative to currently existing dose regimens, a high-dose bupropion E...
Efficacy and Safety of Angiotensin-Based Pharmacotherapy versus Conventional Therapy for the Management of Isolated Systolic Hypertension: A Meta-Analysis of Randomized Controlled Trials
The angiotensin (AT) system is highly implicated in the pathophysiology of isolated systolic hypertension (ISH). Consequently, this meta-analysis was designed to quantitatively review the efficacy and safety of angiotens...